SI-BONE (SIBN) Set to Announce Earnings on Tuesday

SI-BONE (NASDAQ:SIBN) is set to issue its quarterly earnings data after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

SI-BONE Stock Down 1.6 %

SI-BONE stock opened at $15.32 on Monday. The company has a quick ratio of 8.12, a current ratio of 9.17 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $638.69 million, a PE ratio of -15.17 and a beta of 1.22. The firm’s fifty day moving average is $14.22 and its 200 day moving average is $14.31. SI-BONE has a 12-month low of $11.76 and a 12-month high of $21.70.

Insider Transactions at SI-BONE

In related news, insider Anthony J. Recupero sold 3,305 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $13.58, for a total value of $44,881.90. Following the transaction, the insider now owns 233,412 shares of the company’s stock, valued at approximately $3,169,734.96. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Anthony J. Recupero sold 3,305 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $13.58, for a total transaction of $44,881.90. Following the completion of the sale, the insider now owns 233,412 shares in the company, valued at approximately $3,169,734.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Anthony J. Recupero sold 3,905 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $13.84, for a total value of $54,045.20. Following the transaction, the insider now owns 238,804 shares in the company, valued at approximately $3,305,047.36. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,017 shares of company stock valued at $349,587 over the last three months. Corporate insiders own 3.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SIBN. Morgan Stanley cut their price objective on shares of SI-BONE from $21.00 to $19.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Truist Financial cut their price target on SI-BONE from $18.00 to $16.00 and set a “buy” rating on the stock in a report on Monday, October 14th. Finally, Needham & Company LLC decreased their price objective on SI-BONE from $27.00 to $19.00 and set a “buy” rating for the company in a report on Tuesday, August 6th. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $22.67.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.